EPISODE · Mar 7, 2024 · 37 MIN
Market and Reimbursement Outlook for Cell and Gene Therapies
from Votes & Verdicts · host Bloomberg
Cell and gene therapies are a scientific advancement that can treat previously uncurable diseases. Yet absent a national coverage and payment framework, they will remain out of reach for patients, according to Amanda Katchmar and Alan Cohen from Boston University. They join Bloomberg Intelligence analysts Duane Wright and Ann-Hunter Van Kirk on this episode of the Votes & Verdicts podcast to discuss the pipeline for cell and gene therapies and the coverage and reimbursement outlook.See omnystudio.com/listener for privacy information.
NOW PLAYING
Market and Reimbursement Outlook for Cell and Gene Therapies
No transcript for this episode yet
Similar Episodes
Jul 8, 2026 ·29m
Jul 6, 2026 ·84m
Jul 4, 2026 ·23m
Jul 4, 2026 ·89m
Jun 27, 2026 ·20m